Literature DB >> 35927598

Response to: Commentary on: "Nationwide Validation of the 8th American Joint Committee on Cancer TNM Staging System and Five Proposed Modifications for Resected Pancreatic Cancer".

T J Schouten1, L A Daamen1,2, H C van Santvoort1, I Q Molenaar3.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35927598     DOI： 10.1245/s10434-022-12168-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   4.339


× No keyword cloud information.
  9 in total

Review 1.  Meta-analysis of radical resection rates and margin assessment in pancreatic cancer.

Authors:  M D Chandrasegaram; D Goldstein; J Simes; V Gebski; J G Kench; A J Gill; J S Samra; N D Merrett; A J Richardson; A P Barbour
Journal:  Br J Surg       Date:  2015-09-09       Impact factor: 6.939

Review 2.  Resection margins in pancreatic cancer.

Authors:  C S Verbeke
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

3.  Impact of Margin Status on Survival in Patients with Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy.

Authors:  Ryan K Schmocker; Daniel Delitto; Michael J Wright; Ding Ding; John L Cameron; Kelly Lafaro; William R Burns; Christopher L Wolfgang; Richard A Burkhart; Jin He
Journal:  J Am Coll Surg       Date:  2020-12-15       Impact factor: 6.113

4.  Optimized modification of the eighth edition of AJCC TNM staging system for resected pancreatic ductal adenocarcinoma.

Authors:  Ning Pu; Lingdi Yin; Joseph R Habib; Shanshan Gao; Haijie Hu; Yayun Zhu; Yong Wu; Jun Yu; Wenhui Lou
Journal:  Future Oncol       Date:  2019-08-28       Impact factor: 3.404

5.  Response to: Commentary on: "Nationwide Validation of the 8th American Joint Committee on Cancer TNM Staging System and Five Proposed Modifications for Resected Pancreatic Cancer".

Authors:  T J Schouten; L A Daamen; H C van Santvoort; I Q Molenaar
Journal:  Ann Surg Oncol       Date:  2022-08-04       Impact factor: 4.339

6.  Amsterdam International Consensus Meeting: tumor response scoring in the pathology assessment of resected pancreatic cancer after neoadjuvant therapy.

Authors:  Boris V Janssen; Faik Tutucu; Stijn van Roessel; Volkan Adsay; Olca Basturk; Fiona Campbell; Claudio Doglioni; Irene Esposito; Roger Feakins; Noriyoshi Fukushima; Anthony J Gill; Ralph H Hruban; Jeffrey Kaplan; Bas Groot Koerkamp; Seung-Mo Hong; Alyssa Krasinskas; Claudio Luchini; Johan Offerhaus; Arantza Fariña Sarasqueta; Chanjuan Shi; Aatur Singhi; Thomas F Stoop; Eline C Soer; Elizabeth Thompson; Geertjan van Tienhoven; Marie-Louise F Velthuysen; Johanna W Wilmink; Marc G Besselink; Lodewijk A A Brosens; Huamin Wang; Caroline S Verbeke; Joanne Verheij
Journal:  Mod Pathol       Date:  2020-10-12       Impact factor: 7.842

7.  Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer.

Authors:  Ryan P Merkow; Karl Y Bilimoria; James S Tomlinson; Jennifer L Paruch; Jason B Fleming; Mark S Talamonti; Clifford Y Ko; David J Bentrem
Journal:  Ann Surg       Date:  2014-08       Impact factor: 12.969

8.  Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma.

Authors:  Vincent P Groot; Georgios Gemenetzis; Alex B Blair; Roberto J Rivero-Soto; Jun Yu; Ammar A Javed; Richard A Burkhart; Inne H M Borel Rinkes; I Quintus Molenaar; John L Cameron; Matthew J Weiss; Christopher L Wolfgang; Jin He
Journal:  Ann Surg       Date:  2019-06       Impact factor: 13.787

Review 9.  Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer.

Authors:  E Versteijne; J A Vogel; M G Besselink; O R C Busch; J W Wilmink; J G Daams; C H J van Eijck; B Groot Koerkamp; C R N Rasch; G van Tienhoven
Journal:  Br J Surg       Date:  2018-04-30       Impact factor: 6.939
  9 in total
  2 in total

1.  Response to: Commentary on: "Nationwide Validation of the 8th American Joint Committee on Cancer TNM Staging System and Five Proposed Modifications for Resected Pancreatic Cancer".

Authors:  T J Schouten; L A Daamen; H C van Santvoort; I Q Molenaar
Journal:  Ann Surg Oncol       Date:  2022-08-04       Impact factor: 4.339

2.  ASO Author Reflections: The Need for Improvement of the 8th American Joint Committee on Cancer TNM Staging System for Resected Pancreatic Ductal Adenocarcinoma.

Authors:  Thijs J Schouten; Lois A Daamen; Hjalmar C van Santvoort; I Quintus Molenaar
Journal:  Ann Surg Oncol       Date:  2022-04-19       Impact factor: 4.339
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.